Table 1.
GOLD stage | Descriptor | Signs and symptoms | Spirometry results based on post-bronchodilator FEV1 |
---|---|---|---|
I | Mild | Mildly reduced airflow; sometimes a chronic cough and sputum production | FEV1/FVC < 70 FEV1 ≥ 80% predicted |
II | Moderate | Worsening airflow; shortness of breath typically brought on by exertion | FEV1/FVC < 70 50% ≤ FEV1 < 80% predicted |
III | Severe | Further worsening airflow; greater shortness of breath; reduced quality of life | FEV1/FVC < 70 30% ≤ FEV1 < 50% predicted |
IV | Very severe | Severe reduction of airflow; chronic respiratory failure; greatly reduced quality of life | FEV1/FVC < 70 FEV1 < 30% predicted or FEV1 < 50% predicted plus chronic respiratory failure |
Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.